文献速递胸部肿瘤头颈与中枢神经肿瘤

已切除非小细胞肺癌脑转移的免疫微环境与T细胞受体库受抑制

Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer.
PubMed 文献 · Ann Oncol · 2019-01-01

该研究对39例手术切除的非小细胞肺癌原发灶与配对脑转移灶进行770免疫基因表达谱和TCRβ测序,发现脑转移灶中树突状细胞成熟、Th1和白细胞外渗信号通路受抑,T细胞浸润低而巨噬细胞高,T细胞克隆扩增见于64%脑转移灶,提示脑转移免疫微环境处于免疫抑制状态。

要点

  • 脑转移灶免疫微环境呈免疫抑制表型,T细胞浸润稀疏而巨噬细胞增多。
  • 脑转移灶中树突状细胞成熟、Th1和白细胞外渗信号通路受抑制。
  • 64%脑转移灶存在T细胞克隆扩增,但TCR库与原发灶大部分共享。

核心结论

  • 非小细胞肺癌脑转移的肿瘤免疫微环境呈免疫抑制状态,包含免疫抑制性肿瘤相关巨噬细胞等表型,可能为免疫治疗策略提供指导。

研究设计与样本

  • 对39例手术切除的非小细胞肺癌患者的配对原发灶和脑转移灶石蜡标本进行770免疫基因表达谱分析和TCRβ测序,并行免疫组化验证和靶向测序分析癌症基因热点突变。

主要发现

  • 28/39例(71%)患者的原发灶和脑转移灶共享体细胞热点突变。
  • 脑转移灶相比原发灶有161个差异表达基因,提示树突状细胞成熟、Th1和白细胞外渗信号通路受抑制(P < 0.01)。
  • 脑转移灶中促炎细胞黏附分子血管细胞黏附蛋白1(VCAM1)相比原发灶显著受抑。
  • 脑转移灶相比原发灶T细胞浸润更低而巨噬细胞浸润更高(P < 0.001)。
  • 64%的脑转移灶相比配对原发灶存在T细胞克隆扩增,且TCR库在配对脑转移灶和原发灶间大部分共享,但转移灶中T细胞密度稀疏。

临床怎么用

  • 脑转移灶免疫抑制微环境特征提示可能需要针对免疫抑制性巨噬细胞或联合免疫策略来改善非小细胞肺癌脑转移的免疫治疗疗效。

局限性

  • 样本来自手术切除的存档石蜡标本,样本量39例,可能限制结论的普适性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The tumor immune microenvironment (TIME) of lung cancer brain metastasis is largely unexplored. We carried out immune profiling and sequencing analysis of paired resected primary tumors and brain metastases of non-small-cell lung carcinoma (NSCLC). PATIENTS AND METHODS: TIME profiling of archival formalin-fixed and paraffin-embedded specimens of paired primary tumors and brain metastases from 39 patients with surgically resected NSCLCs was carried out using a 770 immune gene expression panel and by T-cell receptor beta repertoire (TCRβ) sequencing. Immunohistochemistry was carried out for validation. Targeted sequencing was carried out to catalog hot spot mutations in cancer genes. RESULTS: Somatic hot spot mutations were mostly shared between both tumor sites (28/39 patients; 71%). We identified 161 differentially expressed genes, indicating inhibition of dendritic cell maturation, Th1, and leukocyte extravasation signaling pathways, in brain metastases compared with primary tumors (P < 0.01). The proinflammatory cell adhesion molecule vascular cell adhesion protein 1 was significantly suppressed in brain metastases compared with primary tumors. Brain metastases exhibited lower T cell and elevated macrophage infiltration compared with primary tumors (P < 0.001). T-cell clones were expanded in 64% of brain metastases compared with their corresponding primary tumors. Furthermore, while TCR repertoires were largely shared between paired brain metastases and primary tumors, T-cell densities were sparse in the metastases. CONCLUSION: We present findings that suggest that the TIME in brain metastases from NSCLC is immunosuppressed and comprises immune phenotypes (e.g. immunosuppressive tumor-associated macrophages) that may help guide immunotherapeutic strategies for NSCLC brain metastases.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Kudo Y, Haymaker C, Zhang J, et al. Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer. Ann Oncol. 2019. PMID: 31282941. doi:10.1093/annonc/mdz207

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。